4:00 PM SIGN-IN • 4:30 PM - 6:00 PM

BANDOL 2 (NEW WYNN SPACE)

CE: Multiple Sclerosis Update: Clinical, Economic, and Patient-Centric Strategies for Specialty Pharmacy Professionals

More than a dozen disease-modifying therapies (DMTs) are available for the treatment of MS with several additional novel therapies in late stage development. Early diagnosis and aggressive treatment is essential to minimize the MS disease burden and limit use of limited health care resources. Therefore, a high level of disease and therapeutic knowledge is necessary to effectively and efficiently manage the disease. The continually evolving MS treatment landscape accentuates the need for increased disease and therapeutic knowledge amongst managed care and specialty pharmacy professionals in order to optimize clinical outcomes, reduce treatment variability, and increase patient engagement in their own care. This program highlights opportunities for managed care and specialty pharmacy professionals to enhance the management of patients with MS by implementing and/or recommending evidence-driven practices and administrative routines based on current clinical trial data.

Speakers

Alexis Crispino

Mitzi Joi Williams

Michael Zeglinski

Asembia

200 Park Avenue, Suite 300 
Florham Park, NJ 07932

973.564.8004

asembia.com

info@asembiasummit.com

SIGN UP FOR SUMMIT UPDATES

Asembia's Specialty Pharmacy Summit is a PRIVATE EVENT. Asembia reserves the right to deny registration and refuse access at our absolute and sole discretion for any reason whatsoever.

Virtual Experience Terms & Conditions

© 2020 Asembia Specialty Pharmacy Summit, LLC. All rights reserved.

CONNECT WITH US

  • Asembia LinkedIn
  • Asembia Twitter
  • Asembia Instagram
  • Asembia Facebook
  • Asembia Videos
  • Asembia Photos
SummitLogo_2020_White.png